| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Bosentan | FAERS: 2 | OFFSIDES US FAERS | |
| 2 | Citalopram | FAERS: 2 | US FAERS | |
| 3 | Lopinavir | FAERS: 2 | US FAERS | |
| 4 | Propylthiouracil | FAERS: 2 | OFFSIDES US FAERS | |
| 5 | Paroxetine | FAERS: 1 | US FAERS | |
| 6 | Valproic Acid | FAERS: 1 | US FAERS | |
| 7 | Venlafaxine Hydrochloride | FAERS: 1 | US FAERS | |
| 8 | Atazanavir Sulfate | OFFSIDES | ||
| 9 | Cabergoline | OFFSIDES | ||
| 10 | Deamino Arginine Vasopressin | OFFSIDES | ||
| 11 | Mexiletine | OFFSIDES | ||
| 12 | Nevirapine | OFFSIDES | ||
| 13 | Tenofovir | OFFSIDES | ||
| 14 | Zidovudine | OFFSIDES | ||
| 15 | abacavir, lamivudine drug combination | OFFSIDES |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.